Goldman Sachs upgraded NuVasive (NASDAQ: NUVA) from Neutral to Buy with a price target of $43.00 (from $38.00).Analyst David H ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE